Publications

November 2017
Case

BeiGene

By: Willy Shih and Jimmy Zhang

BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window... View Details

Keywords: Biotechnology; Pharmaceutical Company; Pharmaceuticals; China; Regulatory Environment; Business Strategy; Business Startups; Innovation Strategy; Situation or Environment; Pharmaceutical Industry; China

10 Jul 2006
Working Paper Summaries

Nationality and Multinationals in Historical Perspective

Keywords: by Geoffrey G. Jones

02 Sep 2002
Research & Ideas

Foreign Multinationals in the U.S.: A Rocky Road

What can companies today take away from the experience of myriad multinationals in the United States? A lot, says HBS professor Geoffrey G. Jones, a specialist in business history and international business.... View Details

Keywords: by Sarah Jane Johnston & Martha Lagace

01 Mar 2007
News

Daniel Vasella

portfolio of product lines, setting Novartis apart from its global competitors. Although initially regarded by critics as too inexperienced to lead a multinational pharmaceutical company, Vasella has... View Details

Keywords: Roger Thompson; multinational pharmaceutical company; prescription drugs; vaccines; Medicare; generics business; Health, Social Assistance

14 Mar 2014
HBS Seminar

Jeremy M. Levin, former President and CEO, Teva Pharmaceutical Industries

May 2011
Case

The Morrison Company

By: Steven C. Wheelwright and Paul Meyers

The Morrison Company develops and manufactures radio frequency identification tags (RFID) known as smart labels for the retail and pharmaceutical industries. RFID technology is a fast-growing and increasingly competitive industry. Sales have risen dramatically over the... View Details

Keywords: Quantitative Analysis; Technology; Operations Management; Product Lines; Manufacturing; Capacity Planning; Production Planning; Information Technology; Strategy; Production; Organizational Structure; Infrastructure; Product Development; Information Infrastructure; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry; Pharmaceutical Industry

August 2001
Case

Pharmaceutical Industry and the AIDS Crisis in Developing Countries, The

Explores the controversy over the pricing of AIDS drugs in poor countries. This issue has received wide publicity due to two events: 1) a court case in South Africa that seeks to force drug companies to license their patents and 2) the announcement by the Indian... View Details

Keywords: Competition; Developing Countries and Economies; Business and Government Relations; Pharmaceutical Industry; South Africa; India

May 2016
Case

AbbVie

By: Kevin Schulman, Laura Little, Samyukta Mullangi and Stephen Schleicher

This case focuses on the impact of a novel regulatory pathway, the biosimilars pathway, on the strategy of a major pharmaceutical firm that finds its largest product (60% of revenue) at risk. The case reviews the rationale for the pathway, the emerging biosimilars... View Details

Keywords: Pharmaceutical Company; M＆A Valuation; AbbVie; Health Care; Health Care and Treatment; Pharmaceutical Industry; Pharmaceutical Industry; United States

12 Mar 2014
Research & Ideas

Entrepreneurship and Multinationals Drive Globalization

company Beiersdorf is the most dramatic. Beiersdorf faced the worst of all worlds in terms of political risk. It was a determined multinational investor before World War I, and then lost everything as the... View Details

Keywords: by Sean Silverthorne; Pharmaceutical; Pharmaceutical; Pharmaceutical; Pharmaceutical

January 2018
Supplement

BeiGene Supplemental PowerPoint

By: Willy C. Shih and Jimmy Zhang

BeiGene was a biopharmaceutical company founded on exploiting a temporal regulatory policy discontinuity. Because of regulatory challenges in China, most innovative new drugs launched there four to six years after their initial U.S. launches. This gave BeiGene a window... View Details

Keywords: Biotechnology; Pharmaceutical Company; Pharmaceuticals; China; Regulatory Environment; Business Strategy; Innovation Strategy; Situation or Environment; Pharmaceutical Industry; Pharmaceutical Industry; China

27 Jan 2011
News

The Gender Advantage for Multinational Firms

October 2007 (Revised July 2013)
Case

Vertex Pharmaceuticals and the Cystic Fibrosis Foundation: Venture Philanthropy Funding for Biotech

By: Robert F. Higgins, Sophie LaMontagne and Brent Kazan

In 2001, Vertex Pharmaceuticals Incorporated acquired the San Diego-based biotech company, Aurora Biosciences. The combination of Vertex's and Aurora's technologies would improve the flow of novel drug candidates into development. However, several questions related to... View Details

Keywords: Philanthropy; Philanthropy Funding; Innovation; Funding Model; Venture Capital; Partners and Partnerships; Financing and Loans; Investment Funds; Acquisition; Philanthropy and Charitable Giving; Pharmaceutical Industry; Pharmaceutical Industry; San Diego

July 2003 (Revised August 2003)
Case

Lamoiyan Corporation of the Philippines: Challenging Multinational Giants

A local Philippine toothpaste manufacturer, Lamoiyan Corp., faces the challenge of staying competitive against entrenched multinational giants. The company has managed to capture, at its peak, 20% of the Philippine toothpaste market and has become the number three... View Details

Keywords: Multinational Firms and Management; Competitive Strategy; Emerging Markets; Entrepreneurship; Consumer Products Industry; Philippines

01 Nov 2013
HBS Seminar

Eric Olson, Chief Scientific Officer at Syros Pharmaceuticals

January 1994
Article

Foreign Multinationals in British Manufacturing, 1850-1962

By: G. Jones and Frances Bostock

This article draws on a new database to describe the dimensions and characteristics of 685 foreign companies which established British manufacturing subsidiaries between 1850 and 1962. The numbers of foreign companies grew from the 1890s, expanded rapidly in the... View Details

Keywords: Multinational Firms and Management; Business Subsidiaries; Expansion; Chemicals; Metals and Minerals; Food; Mergers and Acquisitions; Market Entry and Exit; Research and Development; Trade; Investment; Production; United Kingdom; United States; Scotland; Wales

Find at Harvard

June 2002 (Revised November 2005)
Case

Life, Death, and Property Rights: The Pharmaceutical Industry Faces AIDS in Africa

By: Debora L. Spar

In the final years of the 20th century, the world was hit by a plague of epidemic proportions--AIDS, a life-threatening disease that remained stubbornly immune to any cure or vaccine. In the developed nations of the West, AIDS was slowly brought under control through a... View Details

Keywords: Patents; Health Pandemics; Corporate Social Responsibility and Impact; Pharmaceutical Industry; Africa